Value-Based Pricing: UK Set to Begin Negotiations on New Brand Drugs Scheme

International Pharmaceutical Regulatory Monitor
A A
Negotiations on the future of UK pricing and reimbursement policies for brand drugs will begin in September, according to a joint statement by the Department of Health and the Association of the British Pharmaceutical Industry (ABPI).

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00